Online Program

A video introduction to rectal microbicide clinical trials

Tuesday, November 5, 2013 : 1:15 p.m. - 1:24 p.m.

Clare Collins, M.A., M.Ed., Magee-Womens Research Institute, Microbicide Trials Network, Pittsburgh, PA
Jim Pickett, AIDS Foundation of Chicago, AIDS Foundation of Chicago, Chicago, IL
Barbara Friedland, MPH, HIV and AIDS Program, Population Council, New York, NY
Rectal microbicides (RMs) are products being developed to prevent HIV, and potentially other sexually transmitted infections during receptive anal intercourse. Unprotected receptive anal intercourse is the primary driver of the HIV epidemic among gay men and other men who have sex with men. As RM research expands from early Phase 1 studies to larger Phase 2 and 3 clinical trials, educational materials are needed to engage people in RM research and describe what it is like to participate in a trial. Given that the field of HIV prevention research is quite complex, it is often challenging to provide communities with accurate and understandable information about the scientific process. To address the need for materials about RMs, the Population Council, the International Rectal Microbicide Advocates, and the Microbicide Trials Network developed a video called The Rectal Revolution is Here: an Introduction to Rectal Microbicide Clinical Trials. The goal of The Rectal Revolution is Here is to encourage participation and interest in RM clinical trials, ensure consistent and accurate messages about RMs, and educate clinic staff and communities. The 14-minute video introduces important concepts that apply to all RM trials, such as voluntary participation, risks and benefits, and clinical research. The video was produced by Paw Print Productions and filmed on location in 2012 in Bangkok, Thailand; at the Desmond Tutu HIV Foundation in Cape Town, South Africa; at Epicentro in Lima, Peru; at Magee-Womens Hospital, University of Pittsburgh Medical Center, Pittsburgh, PA, USA; and in the laboratories of the Center for Biomedical Research, Population Council, New York, NY, USA. The video is available in English, Spanish, and Thai.

Learning Areas:

Advocacy for health and health education
Communication and informatics
Diversity and culture
Planning of health education strategies, interventions, and programs

Learning Objectives:
Identify the risks of HIV from unprotected anal intercourse. Explain rectal microbicide (RM) development and testing and the relationship of RMs to condom use. Describe the risks and benefits to participating in clinical trials for rectal microbicides. Discuss how rectal microbicides work and who could potentially benefit from their use.

Keyword(s): HIV/AIDS, Prevention

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: As Associate Director of Communications & External Relations at the Microbicide Trials Network, I have developed educational materials and implemented communications plans to promote understanding of rectal microbicides and biomedical HIV prevention. My areas of expertise include supporting communications and media relations efforts of U.S. and international clinical trial sites through training, materials and other communication-related services.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.